Scleroderma Types, Pictures, and Symptoms

Scleroderma is a chronic autoimmune disease of the connective tissue that causes a hardening and tightening of the skin. (Scleroderma means "hard skin" in Greek). The disease can be localized, with symptoms related entirely to the skin, or it can be systemic, in which hardening can occur in connective tissues within the body.

Nearly everyone with scleroderma develops patches of thick, hardened skin. Other common symptoms include muscle and joint pain, gastrointestinal (GI) issues, swollen hands, narrowing of blood vessels, calcium deposits under the skin, and more.

This article discusses the two main forms of scleroderma and their symptoms. It also includes scleroderma pictures and covers potential complications of the condition.

scleroderma symptoms

Verywell / Emily Roberts

Types of Scleroderma

The two main categories of scleroderma include:

  • Localized scleroderma, which affects the skin and occasionally the underlying muscles or joints
  • Systemic sclerosis, which involves blood vessels and internal organs throughout the body

Localized scleroderma affects mostly children and is less severe than systemic sclerosis, which is more common in adults. The causes of scleroderma are still unknown, but it is believed to be related to a buildup of collagen (a protein in connective tissue) in the skin and an abnormal immune system response.

Localized scleroderma may appear in one spot or in several patches or regions of the skin. It has the following two main subtypes.

  • Linear scleroderma: Lesions look like straight lines or streaks.
  • Morphea scleroderma: Reddish oval patches form.

What Triggers a Scleroderma Flare-Up?

It's not clear what exactly causes scleroderma, however, certain environmental triggers have been linked to the condition. These potential triggers include exposure to silica and certain solvents and drugs.

Common Symptoms of Localized Scleroderma

Localized scleroderma is a rare condition. Linear scleroderma typically involves both the surface and deeper layers of the skin, but morphea scleroderma doesn't tend to go beyond the surface layers of the epidermis and dermis.

Linear Scleroderma

Linear scleroderma forms into lines as it hardens. It often occurs on one side of the body and can appear as a line down an arm or leg, or sometimes the head. As it spreads to deeper skin layers, it may also involve muscle and bone. Linear scleroderma typically occurs in children.

Common symptoms of linear scleroderma include:

  • Lines or streaks of hardened, waxy skin on the trunk and limbs or face and scalp
  • Skin discoloration that may appear lighter or darker
  • Joint tightness

Morphea Scleroderma

Morphea scleroderma, the more common form of localized scleroderma, most often forms on the abdomen and back. It can also sometimes develop on the face, arms, and legs.

Morphea scleroderma can be limited to one to four small patches (plaque morphea) or in some cases it can spread over large areas of the body (generalized morphea). It most commonly occurs in adults between the ages of 20 and 50, but can also occur in children.

Common symptoms include:

  • Patches of reddish skin that thicken into firm, oval-shaped areas on the abdomen, chest, or back
  • Skin becomes waxy and shiny as it tightens
  • Center of the patches can be ivory or yellow with violet borders
  • Pruritis (itchy skin)

Morphea scleroderma tends to be oval and reddish, but the waxy patches may vary in color, shade (light or dark), size, and shape. The patches may get larger or shrink, and they may disappear spontaneously.

A person with morphea on the skin

Reproduced with permission from ©DermNet New Zealand and © Raimo Suhonen www.dermnetnz.org 2023.

Localized scleroderma typically goes away over time, but it may leave skin discoloration even after it resolves. Linear scleroderma typically lasts two to five years, and morphea lesions last an average of three to five years.

Common Symptoms of Systemic Sclerosis

Systemic sclerosis (SSc) can affect connective tissues in many parts of the body. The two main subtypes are limited cutaneous SSc, which progresses slowly over a period of years, and diffuse cutaneous SSc, which covers more skin area and progresses more quickly to multiple organs and systems.

Limited Cutaneous Systemic Sclerosis

Limited cutaneous SSc is also called CREST syndrome, an acronym for its common conditions and symptoms.

CREST syndrome

People with limited cutaneous SSc may have two or more common features of CREST syndrome:

  • Calcinosis, which are calcium deposits in the skin
  • Raynaud's phenomenon, a spasm of blood vessels in response to cold, stress, or emotional upset that can decrease blood flow in fingers or toes
  • Esophageal dysfunction, which is when smooth muscles that line the esophagus lose normal movement and function
  • Sclerodactyly, a thickening and tightening of the skin of the fingers and hands
  • Telangiectasia, a swelling of capillaries (small blood vessels) near the surface of the skin on the face and hands that causes red spots

Common skin-related symptoms of limited cutaneous SSc include:

  • Fingers or toes that turn blue and/or white when cold and then become bright red when warmed back up
  • Swelling and sausage-like appearance of fingers
  • Skin thickening on the face, arms, and legs
  • Small, hard lumps in or under the skin (calcinosis)
  • Fingers curl due to skin tightening
  • Reduced range of finger motion
  • Waxy, mask-like appearance of the face
  • Tiny red spots on hands and face
  • Abnormal skin dryness

An estimated 95% of SSc cases begin with Raynaud's phenomenon. In limited cutaneous SSc, Raynaud's phenomenon often occurs for several years prior to skin thickening.

Early symptoms of limited cutaneous SSc involve sensitivity and/or swelling of fingers or toes. The swelling of the hands may be especially pronounced in the morning due to muscle inactivity during sleeping hours. Fingers may look sausage-like, making it difficult to close the hand into a fist. Symptoms may subside as the day goes on.

A close up of a person's hands with scleroderma

Reproduced with permission from © DermNet New Zealand www.dermnetnz.org 2023.

Gastrointestinal issues affect up to 90% of people who have SSc. The esophagus is the most commonly involved organ, affecting 67% of people with SSc. The symptoms are due to structural and functional changes of the esophagus that can occur in limited or diffuse cutaneous SSc.

Common esophageal symptoms include:

  • Heartburn (the sensation of burning behind the breast bone)
  • Difficulty or pain while swallowing
  • Regurgitation
  • Hoarseness
  • Mouth ulcers
  • Acid taste in the mouth

The most common symptom is heartburn. This is due to irritation of the esophagus by acid reflux (stomach acid backing up or refluxing up the esophagus).

Sometimes excess collagen collects in the tissue between the lungs' air sacs in people with limited cutaneous SSc, making the lung tissue stiffer and less able to work properly. If the lungs become affected, common additional symptoms include:

  • Persistent cough
  • Shortness of breath

Diffuse Cutaneous Systemic Sclerosis

Raynaud's phenomenon often occurs simultaneously or just prior to skin thickening in those with diffuse cutaneous SSc. Diffuse cutaneous SSc can involve the heart, lungs, kidneys, gastrointestinal tract, and central and peripheral nervous systems.

Common symptoms of diffuse cutaneous SSc include:

  • Swelling and sausage-like appearance of fingers
  • Skin thickening over large areas of the torso, hands, arms, and legs
  • Waxy, mask-like appearance of face
  • CREST syndrome (see above)
  • Skin darkening or a salt-and-pepper appearance 
  • Thinning of lips and furrowing around the mouth
  • Muscle and joint pain and/or stiffness
  • Grating noise with movement of joints
  • Weight loss
  • Fatigue
  • Heartburn
  • Gastroparesis (sensation of nausea, fullness, or bloating from retention of food in stomach)
  • Cramps and/or diarrhea
  • Chronic cough
  • Shortness of breath

Muscle and joint pain may also occur along tendons and in muscles in the arms and legs. This can worsen with movement of the ankles, wrists, knees, or elbows. As the disease progresses, muscle loss and weakness may develop along with swelling, warmth, and tenderness around the joints and muscles.

Often, people with diffuse cutaneous SSc experience a grating noise when they try to move inflamed joints, particularly joints at and below the knees.

In the lower GI tract, diffuse cutaneous SSc can sometimes slow movement of food and reduce food absorption.

In both types of systemic sclerosis, lumps of calcinosis may break through the skin and leak a white substance. The open cuts may then become infected.

Rare Symptoms

There are rare subtypes of localized scleroderma that can sometimes develop into more serious conditions:

  • Subcutaneous morphea affects deeper tissues and can extend deep into muscles.
  • Bullous morphea causes blister-like bumps or areas of erosion on the region of morphea.
  • Generalized morphea may also limit joint function due to its larger coverage areas. In rare cases, the larger lesions can merge together, covering the entire body.
  • En coup de sabre is a rare form of linear scleroderma that affects the head, especially the forehead. Lesions form depressed grooves that resemble a sword wound or the stroke of a saber. If it's on the scalp, hair loss can occur. In rare cases, en coup de sabre can cause abnormalities in the growth of facial bones and, unlike other forms of localized scleroderma, it can recur many years after going away.

Some people with SSc experience additional symptoms that may or may not seem related to the disease. This can include:

  • Trigeminal neuralgia (sudden episodes of severe facial pain)
  • Limited eye movement
  • Severe fatigue and depression

Complications

Scleroderma can cause many complications that range from mild to life-threatening. These usually occur when the disorder has not been treated or when treatment has failed to adequately address symptoms.

Complications of Localized Scleroderma

Complications of localized scleroderma may include the following.

  • Joint pain: About 10% to 20% of people with localized scleroderma develop pain in affected joints.
  • Slowed growth of an arm or leg: Linear scleroderma that extends to muscles and tendons can sometimes stop or slow the growth of the affected limb in children.
  • Co-existing inflammatory arthritis and juvenile idiopathic arthritis: When localized scleroderma and arthritis occur together, lesions can cover arthritic joints, and the arthritis may be less responsive or unresponsive to treatments.

Complications of Systemic Sclerosis

Complications of SSc are most often related to diffuse cutaneous SSc and can involve many organs and body systems. They may include the following.

  • Ulcers on fingers and toes: Severe Raynaud's phenomenon can obstruct blood flow to fingers and toes, causing ulcers that can be difficult to heal. Fingertips may be permanently damaged.
  • Gangrene: In extreme cases, abnormal or narrowed blood vessels combined with severe Raynaud's can lead to gangrene and may necessitate amputation.
  • Incontinence: Weakening of the sphincter muscles and/or abnormal gastrointestinal motility can lead to stool incontinence.
  • Lung damage: Breathing problems due to pulmonary hypertension and scarring of the connective tissue in the lungs can lead to lung disease and, potentially, heart failure.
  • Heart problems: Scarring of heart tissue and narrowed blood vessels can lead to abnormal heart rhythms and, in rare cases, to an inflamed heart muscle (myocarditis).
  • Kidney damage: Restricted blood flow to the kidneys can result in scleroderma renal crisis. If left untreated, this condition can lead to malignant high blood pressure and kidney failure.
  • Dental problems: Severe tightening of facial skin can make it difficult to open your mouth wide enough to brush your teeth. Additionally, acid reflux can destroy tooth enamel, and changes in gum tissue due to scleroderma may cause teeth to become loose or fall out.
  • Dry eyes and mouth: Diffuse cutaneous SSc can cause very dry eyes and mouth, a condition known as Sjogren's syndrome.
  • Gastric antral vascular ectasia syndrome (GAVE): Sometimes called "watermelon stomach," this is a rare condition resulting in red-streaked areas in the stomach from widened blood vessels and iron deficiency anemia. GAVE affects an estimated 5.7% of people with SSc.
  • Sexual dysfunction: Males with scleroderma may experience erectile dysfunction; women may have decreased lubrication and a constricted vaginal opening.
  • Heart failure: Scleroderma-related heart problems may manifest as abnormal heart rhythms or congestive heart failure.
  • Nervous system problems: Headache and dizziness, convulsions, and visual disturbances can occur if the nervous system is affected. In some cases, it can also lead to aphasia (loss of ability to speak and understand language).

Outlook for Scleroderma

The outlook for scleroderma can vary widely from person to person. However, many people with scleroderma—particularly those with limited disease—go on to live normal lifespans.

For others, life expectancy can be affected by many factors including how invasive the disease is and whether serious complications have developed.

While there is no cure for scleroderma, there are treatments available that can help relieve symptoms and prevent complications. Treatment is most effective when started early.

Localized scleroderma typically gets better on its own; there will likely come a time when no new lesions form and the existing ones fade. Systemic sclerosis is manageable with treatments to target affected organs. These treatments are continuously improving and can help with symptoms and improve quality of life.

When to See a Healthcare Provider

Individuals who exhibit symptoms of scleroderma should seek out a physician with expertise in this complex disease, such as a rheumatologist. Early detection of scleroderma can help reduce the risk of serious complications. By recognizing and treating organ involvement in SSc early, you can prevent irreversible damage.

Summary

Scleroderma is a chronic autoimmune disease that causes inflammation and the build up of fibrous tissue in the skin and other areas of the body. The disease may be localized or systemic (affecting the whole body). Symptoms of scleroderma include thickened skin, skin color changes, stiff joints, muscle weakness, visible blood vessels, and more. Although there is no cure for the condition, there are treatments available that can help relieve symptoms and improve your quality of life.

12 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Center for Advancing Translational Sciences. Scleroderma. Updated September 12, 2016.

  2. Johns Hopkins Medicine. Scleroderma risk factors.

  3. Careta MF, Romiti R. Localized scleroderma: Clinical spectrum and therapeutic update. An Bras Dermatol. 2015;90(1):62-73. doi:10.1590/abd1806-4841.20152890

  4. Scleroderma Foundation. What is scleroderma?

  5. National Center for Advancing Translational Sciences. Morphea. Updated February 15, 2018.

  6. Sobolewski P, Maślińska M, Wieczorek M, et al. Systemic sclerosis–multidisciplinary disease: clinical features and treatmentReumatologia. 2019;57(4):221-233. doi:10.5114/reum.2019.87619

  7. Nawaz I, Nawaz Y, Nawaz E, Manan MR, Mahmood A. Raynaud’s phenomenon: reviewing the pathophysiology and management strategiesCureus. 2022;14(1):e21681. doi:10.7759/cureus.21681

  8. Valenzuela A, Song P, Chung L. Calcinosis in scleroderma. Curr Opin Rheumatol 2018;30(6):554-561. doi:10.1097/BOR.0000000000000539

  9. Scleroderma Foundation. Localized scleroderma.

  10. Reiff D, Crayne CB, Mannion ML, Cron RQ. Characteristics of coexisting localized scleroderma and inflammatory arthritisEur J Rheumatol. 2020;7(1):67-71. doi:10.5152/eurjrheum.2019.19147

  11. Parrado RH, Lemus HN, Coral-Alvarado PX, Quintana López G. Gastric antral vascular ectasia in systemic sclerosis: current conceptsInternational Journal of Rheumatology. 2015;2015:1-6. doi:10.1155/2015/762546

  12. American Academy of Dermatology. Scleroderma: Diagnosis and treatment.

Additional Reading
Lana Barhum

By Lana Barhum
Barhum is a freelance medical writer with 15 years of experience with a focus on living and coping with chronic diseases.